The Real-World Logistics of CAR T Therapy: Financial and Practical Considerations
Panelists discuss how a patient and their medical team collaborated to evaluate the differences between ide-cel and cilta-cel CAR T therapies to make an informed treatment decision.
EP: 1.A High-Risk Myeloma Patient’s Path to CAR T: Personal and Clinical Perspectives
EP: 2.Behind the Scenes: Patient Education and Decision-Making for CAR T
EP: 3.Clinical Data Supporting CAR T in Earlier Lines: Updates From the CARTITUDE-1, CARTITUDE-4, and KarMMa-3 Trials
Now Viewing
EP: 4.The Real-World Logistics of CAR T Therapy: Financial and Practical Considerations
Video content above is prompted by the following:
- Please walk us through the process of shared decision-making between you and your health care team. How did you decide between ide-cel and cilta-cel?
Recent Videos
Related Content
